Intravenous fluids (usually shortened to 'IV' fluids) are?liquids given to replace water, sugar and salt?that you might need if you are ill or having an operation, and can't eat or drink as you would normally. IV fluids are given straight into a vein through a drip.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Intravenous (IV) Solutions industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Market Segment by Product Application
Hospital & Clinics
Ambulatory
Home Care
Finally, the report provides detailed profile and data information analysis of leading company.
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Intravenous (IV) Solutions consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Intravenous (IV) Solutions market by identifying its various subsegments.
3.Focuses on the key global Intravenous (IV) Solutions manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Intravenous (IV) Solutions with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Intravenous (IV) Solutions submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Intravenous (IV) Solutions Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Intravenous (IV) Solutions Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Intravenous (IV) Solutions Segment by Type
2.1.1 Peripheral Parenteral Nutrition
2.1.2 Total Parenteral Nutrition
2.2 Market Analysis by Application
2.2.1 Hospital & Clinics
2.2.2 Ambulatory
2.2.3 Home Care
2.3 Global Intravenous (IV) Solutions Market Comparison by Regions (2017-2027)
2.3.1 Global Intravenous (IV) Solutions Market Size (2017-2027)
2.3.2 North America Intravenous (IV) Solutions Status and Prospect (2017-2027)
2.3.3 Europe Intravenous (IV) Solutions Status and Prospect (2017-2027)
2.3.4 China Intravenous (IV) Solutions Status and Prospect (2017-2027)
2.3.5 Japan Intravenous (IV) Solutions Status and Prospect (2017-2027)
2.3.6 Southeast Asia Intravenous (IV) Solutions Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Intravenous (IV) Solutions Industry Impact
2.5.1 Intravenous (IV) Solutions Business Impact Assessment - Covid-19
2.5.2 Market Trends and Intravenous (IV) Solutions Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Intravenous (IV) Solutions Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Intravenous (IV) Solutions Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Intravenous (IV) Solutions Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Intravenous (IV) Solutions Manufacturer Market Share
3.5 Top 10 Intravenous (IV) Solutions Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Intravenous (IV) Solutions Market
3.7 Key Manufacturers Intravenous (IV) Solutions Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Intravenous (IV) Solutions Industry Key Manufacturers
4.1 ICU Medical Inc. (U.S.)
4.1.1 Compan Detail
4.1.2 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product Introduction, Application and Specification
4.1.3 ICU Medical Inc. (U.S.) 137 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 ICU Medical Inc. (U.S.) News
4.2 B. Braun Melsungen AG (Germany)
4.2.1 Compan Detail
4.2.2 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Introduction, Application and Specification
4.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 ICU Medical Inc. (U.S.) News
4.3 Fresenius Kabi AG (Germany)
4.3.1 Compan Detail
4.3.2 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Introduction, Application and Specification
4.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Fresenius Kabi AG (Germany) News
4.4 Baxter (U.S.)
4.4.1 Compan Detail
4.4.2 Baxter (U.S.) Intravenous (IV) Solutions Product Introduction, Application and Specification
4.4.3 Baxter (U.S.) Intravenous (IV) Solutions Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Baxter (U.S.) News
4.5 Amanta Healthcare (India)
4.5.1 Compan Detail
4.5.2 Baxter (U.S.) Intravenous (IV) Solutions Product Introduction, Application and Specification
4.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Amanta Healthcare (India) News
4.6 Terumo Medical Corporation (Tokyo)
4.6.1 Compan Detail
4.6.2 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Introduction, Application and Specification
4.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Terumo Medical Corporation (Tokyo) News
4.7 Grifols S.A. (Spain)
4.7.1 Compan Detail
4.7.2 Grifols S.A. (Spain) Intravenous (IV) Solutions Product Introduction, Application and Specification
4.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
5 Global Intravenous (IV) Solutions Market Segment by Big Type
5.1 Global Intravenous (IV) Solutions Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Intravenous (IV) Solutions Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Intravenous (IV) Solutions Revenue and Market Share by Big Type (2017-2022)
5.2 Peripheral Parenteral Nutrition Sales Growth Rate and Price
5.2.1 Global Peripheral Parenteral Nutrition Sales Growth Rate (2017-2022)
5.2.2 Global Peripheral Parenteral Nutrition Price (2017-2022)
5.3 Total Parenteral Nutrition Sales Growth Rate and Price
5.3.1 Global Total Parenteral Nutrition Sales Growth Rate (2017-2022)
5.3.2 Global Total Parenteral Nutrition Price (2017-2022)
6 Global Intravenous (IV) Solutions Market Segment by Big Application
6.1 Global Intravenous (IV) Solutions Sales Market Share by Big Application (2017-2022)
6.2 Hospital & Clinics Sales Growth Rate (2017-2022)
6.3 Ambulatory Sales Growth Rate (2017-2022)
6.4 Home Care Sales Growth Rate (2017-2022)
7 Global Intravenous (IV) Solutions Forecast
7.1 Global Intravenous (IV) Solutions Revenue, Sales and Growth Rate (2022-2027)
7.2 Intravenous (IV) Solutions Market Forecast by Regions (2022-2027)
7.2.1 North America Intravenous (IV) Solutions Market Forecast (2022-2027)
7.2.2 Europe Intravenous (IV) Solutions Market Forecast (2022-2027)
7.2.3 China Intravenous (IV) Solutions Market Forecast (2022-2027)
7.2.4 Japan Intravenous (IV) Solutions Market Forecast (2022-2027)
7.2.5 Southeast Asia Intravenous (IV) Solutions Market Forecast (2022-2027)
7.2.6 Other Regions Intravenous (IV) Solutions Market Forecast (2022-2027)
7.3 Intravenous (IV) Solutions Market Forecast by Type (2022-2027)
7.3.1 Global Intravenous (IV) Solutions Sales Forecast by Type (2022-2027)
7.3.2 Global Intravenous (IV) Solutions Market Share Forecast by Type (2022-2027)
7.4 Intravenous (IV) Solutions Market Forecast by Application (2022-2027)
7.4.1 Global Intravenous (IV) Solutions Sales Forecast by Application (2022-2027)
7.4.2 Global Intravenous (IV) Solutions Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Intravenous (IV) Solutions Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Intravenous (IV) Solutions Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Intravenous (IV) Solutions
Figure Market Concentration Ratio and Market Maturity Analysis of Intravenous (IV) Solutions
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Intravenous (IV) Solutions Market Size by Big Type
Figure Global Market Share of Intravenous (IV) Solutions by Big Type in 2021
Figure Peripheral Parenteral Nutrition Picture (2017-2022)
Global Intravenous (IV) Solutions Market Size by Big Application
Table Global Intravenous (IV) Solutions Market Size by Application
Figure Global Intravenous (IV) Solutions Market Share by Big Application in 2021
Figure Hospital & Clinics Picture
Figure Ambulatory Picture
Figure Home Care Picture
Table Global Intravenous (IV) Solutions Comparison by Regions (M USD) (2017-2027)
Figure Global Intravenous (IV) Solutions Market Size (Million US$) (2017-2027)
Figure North America Intravenous (IV) Solutions Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Intravenous (IV) Solutions Revenue (Million US$) Growth Rate (2017-2027)
Figure China Intravenous (IV) Solutions Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Intravenous (IV) Solutions Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Intravenous (IV) Solutions Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Intravenous (IV) Solutions Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Intravenous (IV) Solutions Sales by Manufacturer (2017-2022)
Figure Global Intravenous (IV) Solutions Sales Market Share by Manufacturer in 2021
Table Global Intravenous (IV) Solutions Revenue by Manufacturer (2017-2022)
Figure Global Intravenous (IV) Solutions Revenue Market Share by Manufacturer in 2021
Table Global Intravenous (IV) Solutions Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Intravenous (IV) Solutions Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Intravenous (IV) Solutions Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Intravenous (IV) Solutions Market
Table Key Manufacturers Intravenous (IV) Solutions Product Type
Table Mergers & Acquisitions Planning
Table ICU Medical Inc. (U.S.) Company Profile
Table Intravenous (IV) Solutions Product Introduction, Application and Specification of ICU Medical Inc. (U.S.)
Table Intravenous (IV) Solutions Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table B. Braun Melsungen AG (Germany) Company Profile
Table Intravenous (IV) Solutions Product Introduction, Application and Specification of B. Braun Melsungen AG (Germany)
Table Intravenous (IV) Solutions Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table B. Braun Melsungen AG (Germany) Recent Development
Table Fresenius Kabi AG (Germany) Company Profile
Table Intravenous (IV) Solutions Product Introduction, Application and Specification of Fresenius Kabi AG (Germany)
Table Intravenous (IV) Solutions Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Fresenius Kabi AG (Germany) Main Business
Table Fresenius Kabi AG (Germany) Recent Development
Table Baxter (U.S.) Company Profile
Table Intravenous (IV) Solutions Product Introduction, Application and Specification of Baxter (U.S.)
Table Intravenous (IV) Solutions Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Baxter (U.S.) Main Business
Table Baxter (U.S.) Recent Development
Table Baxter (U.S.) Main Business
Table Baxter (U.S.) Recent Development
Table Amanta Healthcare (India) Company Profile
Table Intravenous (IV) Solutions Product Introduction, Application and Specification of Amanta Healthcare (India)
Table Intravenous (IV) Solutions Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Amanta Healthcare (India) Main Business
Table Amanta Healthcare (India) Recent Development
Table Terumo Medical Corporation (Tokyo) Company Profile
Table Intravenous (IV) Solutions Product Introduction, Application and Specification of Terumo Medical Corporation (Tokyo)
Table Intravenous (IV) Solutions Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Terumo Medical Corporation (Tokyo) Main Business
Table Terumo Medical Corporation (Tokyo) Recent Development
Table Grifols S.A. (Spain) Company Profile
Table Intravenous (IV) Solutions Product Introduction, Application and Specification of Grifols S.A. (Spain)
Table Intravenous (IV) Solutions Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Grifols S.A. (Spain) Main Business
Table Grifols S.A. (Spain) Recent Development
Figure Global Intravenous (IV) Solutions Sales and Growth Rate (2017-2022)
Figure Global Intravenous (IV) Solutions Revenue and Growth Rate (2017-2022)
Table Global Intravenous (IV) Solutions Sales by Regions (2017-2022)
Figure Global Intravenous (IV) Solutions Sales Market Share by Regions in 2021
Table Global Intravenous (IV) Solutions Revenue by Regions (2017-2022)
Figure Global Intravenous (IV) Solutions Revenue Market Share by Regions in 2021
Figure North America Intravenous (IV) Solutions Sales and Growth Rate (2017-2022)
Figure Europe Intravenous (IV) Solutions Sales and Growth Rate (2017-2022)
Figure China Intravenous (IV) Solutions Sales and Growth Rate (2017-2022)
Figure Japan Intravenous (IV) Solutions Sales and Growth Rate (2017-2022)
Figure Southeast Asia Intravenous (IV) Solutions Sales and Growth Rate (2017-2022)
Figure Other Regions Intravenous (IV) Solutions Sales and Growth Rate (2017-2022)
Table Global Intravenous (IV) Solutions Sales by Big Type (2017-2022)
Table Global Intravenous (IV) Solutions Sales Market Share by Big Type (2017-2022)
Figure Global Intravenous (IV) Solutions Sales Market Share by Big Type in 2019
Table Global Intravenous (IV) Solutions Revenue by Big Type (2017-2022)
Table Global Intravenous (IV) Solutions Revenue Market Share by Big Type (2017-2022)
Table Global Intravenous (IV) Solutions Revenue Market Share by Big Type in 2019
Figure Global Peripheral Parenteral Nutrition Sales Growth Rate (2017-2022)
Figure Global Peripheral Parenteral Nutrition Price (2017-2022)
Figure Global Total Parenteral Nutrition Sales Growth Rate (2017-2022)
Table Global Intravenous (IV) Solutions Sales by Big Application (2017-2022)
Table Global Intravenous (IV) Solutions Sales Market Share by Big Application (2017-2022)
Figure Global Intravenous (IV) Solutions Sales Market Share by Big Application in 2019
Figure Global Hospital & Clinics Sales Growth Rate (2017-2022)
Figure Global Ambulatory Sales Growth Rate (2017-2022)
Figure Global Home Care Sales Growth Rate (2017-2022)
Figure Global Intravenous (IV) Solutions Sales and Growth Rate (2022-2027)
Figure Global Intravenous (IV) Solutions Revenue and Growth Rate (2022-2027)
Table Global Intravenous (IV) Solutions Sales Forecast by Regions (2022-2027)
Table Global Intravenous (IV) Solutions Market Share Forecast by Regions (2022-2027)
Figure North America Sales Intravenous (IV) Solutions Market Forecast (2022-2027)
Figure Europe Sales Intravenous (IV) Solutions Market Forecast (2022-2027)
Figure China Sales Intravenous (IV) Solutions Market Forecast (2022-2027)
Figure Japan Sales Intravenous (IV) Solutions Market Forecast (2022-2027)
Figure Southeast Asia Sales Intravenous (IV) Solutions Market Forecast (2022-2027)
Figure Other Regions Sales Intravenous (IV) Solutions Market Forecast (2022-2027)
Table Global Intravenous (IV) Solutions Sales Forecast by Type (2022-2027)
Table Global Intravenous (IV) Solutions Market Share Forecast by Type (2022-2027)
Table Global Intravenous (IV) Solutions Sales Forecast by Application (2022-2027)
Table Global Intravenous (IV) Solutions Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous (IV) Solutions
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Intravenous (IV) Solutions Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Intravenous (IV) Solutions Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Intravenous (IV) Solutions Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Intravenous (IV) Solutions Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Intravenous (IV) Solutions Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Intravenous (IV) Solutions Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Intravenous (IV) Solutions Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Intravenous (IV) Solutions Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)